Sign inJoin waitlistJoin the waitlist

Jonathan Paul Piccini

Director, Cardiac Electrophysiology Section · Duke Department of Medicine

Credentials: ·

History

Duke Department of Medicine
Present
Duke Department of Medicine
Present
Duke Department of Medicine
Present

Duke University Hospital
Northwestern University Feinberg Medical School
2002

Research

Rivaroxaban versus warfarin in nonvalvular atrial fibrillation
New England Journal of Medicine · 2011 · 7,354 citations
2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee…
Circulation · 2024 · 2,337 citations
Effect of Catheter Ablation vs Antiarrhythmic Drug Therapy on Mortality, Stroke, Bleeding, and Cardiac Arrest Among Patients With Atrial Fibrillation: The CABANA Randomized…
JAMA · 2019 · 1,197 citations

Kenneth Mahaffey
133 papers
GF
Gregg Fonarow
113 papers
Eric Peterson
111 papers
Benjamin Steinberg
92 papers · 40 as a fellow
Peter Kowey
91 papers
DS
Daniel Singer
84 papers
BG
Bernard Gersh
82 papers
Manesh Patel
82 papers
Sean Pokorney
81 papers
Elaine Hylek
53 papers
CN
Christopher Nessel
48 papers
James Freeman
48 papers · 1 as a fellow

Grants

(1/2) Catheter Ablation Versus Antiarrhythmic and Heart Failure Drug Therapy in Preserved Ejection Fraction Heart Failure (CABANA-HF)
National Heart, Lung, and Blood Institute · UG3
PI · $1.3M · Ihc Health Services, Inc.
2026–2027
Neurocognition and Greater Maintenance of Sinus Rhythm in AF (NOGGIN AF)
National Institute on Aging · R01
PI · $3.7M · Duke University
2021–2027

Clinical trials

Early Dronedarone Versus Usual Care to Improve Outcomes in Persons With Newly Diagnosed Atrial Fibrillation
Principal investigator · Completed · Phase 4
American Heart Association
2021–2024
DEFINE AFib (Atrial Fibrillation)
Principal investigator · Terminated
Medtronic Cardiac Rhythm and Heart Failure
2021–2024
Human Use Condition Study- Evaluation of Implanted Leads in Humans
Principal investigator · Completed
Duke University
2021–2022
Genetically Targeted Therapy for the Prevention of Symptomatic Atrial Fibrillation in Patients With Heart Failure
Principal investigator · Completed · Phase 2
ARCA Biopharma, Inc.
2014–2017